Home
Storia in 1 fonti
FDA revisits a rare cancer treatment it rejected a few months ago
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Raccontata da
statnews.com
Timeline cronologica
- ·
FDA to reconsider treatment for rare cancer after its surprise rejection
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
- ·
FDA revisits a rare cancer treatment it rejected a few months ago
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
- ·
The biotech news you need to read today
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout